SPY322.50-8.15 -2.46%
DIA268.03-8.49 -3.07%
IXIC10,614.87-178.42 -1.65%

B. Riley Maintains Buy on OptimizeRx, Lowers Price Target to $20

B. Riley maintains OptimizeRx (NASDAQ:OPRX) with a Buy and lowers the price target from $21 to $20.

Benzinga · 12/30/2019 13:45

B. Riley maintains OptimizeRx (NASDAQ:OPRX) with a Buy and lowers the price target from $21 to $20.